Citation Impact
Citing Papers
Photodynamic therapy for non-melanoma skin cancer
2005
Cutaneous ultraviolet exposure and its relationship to the development of skin cancer
2008
Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial
2008
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up.
2008
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
2017
Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma
2014
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017
Inference and analysis of cell-cell communication using CellChat
2021 Standout
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis
2020
Laser and Non-laser Light Sources for Photodynamic Therapy
2002
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
2016
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
2015
Photodynamic Therapy: Other Uses
2007
Vascular effects of photodynamic and pulsed dye laser therapy protocols
2008
Myasthenia Gravis
2016 Standout
Adherence to medication in patients with psoriasis: a systematic literature review
2012
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Rheumatoid arthritis
2016 Standout
The role of apoptosis in response to photodynamic therapy: what, where, why, and how
2002
Photodynamic therapy for acne vulgaris: A critical review from basics to clinical practice
2010
Antibodies to watch in 2016
2015
Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin
2006
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study
2013
OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results
2014
In vitro and in vivo activities of verteporfin-loaded nanoparticles
2005
Vitamin D Enhances ALA-Induced Protoporphyrin IX Production and Photodynamic Cell Death in 3-D Organotypic Cultures of Keratinocytes
2006
Atopic dermatitis
2015 Standout
Photothermally enhanced photodynamic therapy based on mesoporous Pd@Ag@mSiO2 nanocarriers
2012
Scalp psoriasis: European consensus on grading and treatment algorithm
2009
Photodynamic therapy of cancer. Basic principles and applications
2008
Vitamin D Deficiency
2007 Standout
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
2017
Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy
2004
The changing landscape of atherosclerosis
2021 StandoutNature
Guidelines of care for the management of psoriasis and psoriatic arthritis
2009
Psoriasis
2021 Standout
Seeing the Wood through the Trees: A Review of Techniques for Distinguishing Green Fluorescent Protein from Endogenous Autofluorescence
2001
Nail Psoriasis
2012
Photodynamic therapy for cancer
2003 Standout
Psoriasis: Which therapy for which patient
2018
Alopecia areata update
2010 Standout
Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
2015
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2017
Metazoan MicroRNAs
2018 Standout
Psoriasis
2015 Standout
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
2014
Milestones in the development of photodynamic therapy and fluorescence diagnosis
2007
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions
2015
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Crohn's disease
2016 Standout
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
2017
The influence of photodynamic therapy on the immune response
2005
The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry
2007
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
2020
Acne vulgaris
2011 Standout
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
2020
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis
2020
Intracellular signaling mechanisms in photodynamic therapy
2004
Photodynamic therapy of cancer: An update
2011 Standout
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
2018
Pulsed diode laser-based monitor for singlet molecular oxygen
2008
Time-resolved autofluorescence spectroscopy for classifying normal and premalignant oral tissues
2005
Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial
2016
Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy
2009
Treatment of Diffuse Basal Cell Carcinomas and Basaloid Follicular Hamartomas in Nevoid Basal Cell Carcinoma Syndrome by Wide-Area 5-Aminolevulinic Acid Photodynamic Therapy
2005
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
2010
Imaging chromophores with undetectable fluorescence by stimulated emission microscopy
2009 Nature
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
2017
Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges
2020
Photodynamic therapy in dermatology
2000
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
2018
Fractionated Illumination at Low Fluence Rate Photodynamic Therapy in Mice
2010
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
2013
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy
2012
Recent advances in the prevention and treatment of skin cancer using photodynamic therapy
2010
Biological Therapies for Atopic Dermatitis: A Systematic Review
2021
The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results
2008
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
Clinical PD/PDT in North America: An historical review
2004
Photodynamic therapy: applications in dermatology
2002
X-ray excited ZnS:Cu,Co afterglow nanoparticles for photodynamic activation
2014
Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy
2009
Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis
2016
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Covalently Assembled NIR Nanoplatform for Simultaneous Fluorescence Imaging and Photodynamic Therapy of Cancer Cells
2012
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Abrocitinib for the treatment of atopic dermatitis
2020
IL-10–Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell Function
2016
Antidrug antibodies in psoriasis: a systematic review
2013
Upconverting nanoparticles for pre‐clinical diffuse optical imaging, microscopy and sensing: Current trends and future challenges
2013
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
2016
Comparison of Biologics and Oral Treatments for Plaque Psoriasis
2020
In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy.
2003
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
2015
Adaptive Response of T and B Cells in Atherosclerosis
2016
Psoriasis Pathogenesis and Treatment
2019 Standout
Current states and future views in photodynamic therapy
2011
Ixekizumab provides superior efficacy compared with ustekinumab over 52 weeks of treatment: Results from IXORA-S, a phase 3 study
2018
Foxp3+ T reg cells control psoriasiform inflammation by restraining an IFN-I–driven CD8+ T cell response
2018
Photodynamic Therapy Targets the mTOR Signaling Network in Vitro and in Vivo
2008
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
2021
Nanoparticles in Photodynamic Therapy
2015 Standout
Application of Janus Kinase Inhibitors in Atopic Dermatitis: An Updated Systematic Review and Meta-Analysis of Clinical Trials
2021
Far-Field Autofluorescence Nanoscopy
2010 StandoutNobel
Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study
2017
Dual-Surface Modified Virus Capsids for Targeted Delivery of Photodynamic Agents to Cancer Cells
2010
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
2015
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
2020
In Vivo Studies of Nanostructure‐Based Photosensitizers for Photodynamic Cancer Therapy
2014
Comparison of Coronary Artery Calcium Scores Between Patients With Psoriasis and Type 2 Diabetes
2016
BODIPY dyes in photodynamic therapy
2012 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
TYK 2 inhibitors for the treatment of dermatologic conditions: the evolution of JAK inhibitors
2021
Upconversion Luminescent Materials: Advances and Applications
2014 Standout
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer
2015
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Reversible Photochemical Control of Singlet Oxygen Generation Using Diarylethene Photochromic Switches
2014 StandoutNobel
Enhancement of ALA‐PDT Damage by IR‐lnduced Hyperthermia on a Colon Carcinoma Model
1999
Single-molecule optical spectroscopy of autofluorescent proteins
2002 StandoutNobel
Dye Sensitizers for Photodynamic Therapy
2013
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Noncalcemic Actions of Vitamin D Receptor Ligands
2005
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Long persistent phosphors—from fundamentals to applications
2016 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Photodynamic Therapy in Oncology
2006
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Topical treatments for chronic plaque psoriasis of the scalp: a systematic review
2013
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Works of Robert Bissonnette being referenced
A randomized phase 2a efficacy and safety trial of the topical J anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
2013
Topical tofacitinib for atopic dermatitis: a phase II a randomized trial
2016
Photodynamic Therapy of Multiple Nonmelanoma Skin Cancers With Verteporfinand Red Light–Emitting Diodes
2004
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
2016
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus
2006
Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice
2005
Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester
2002
Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema
2009
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study
2008
IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies
2015
Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice
2002
Protection Afforded by Sunscreens Containing Inorganic Sunscreening Agents Against Blue Light Sensitivity Induced by Aminolevulinic Acid
2008
Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data
2016
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
2018
Alopecia Areata-Like Hair Loss in C3H/HeJ Mice and DEBR Rats Can be Reversed Using Topical Diphencyprone
1999
Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway
2016
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
2015
Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis
2015
Long‐term efficacy of ustekinumab in patients with moderate‐to‐severe psoriasis treated for up to 5 years in the PHOENIX 1 study
2012
Comparison of UVA protection afforded by high sun protection factor sunscreens
2000
Systemic Photodynamic Therapy with Aminolevulinic Acid Induces Apoptosis in Lesional T Lymphocytes of Psoriatic Plaques
2002
Photodynamic therapy with toluidine blue in Jurkat cells: cytotoxicity, subcellular localization and apoptosis induction
2002
Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice
2001
A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis
2010
Chemopreventative Thoughts for Photodynamic Therapy
2007
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
2015
Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid
2004
Psoriatic Plaques Exhibit Red Autofluorescence that is Due to Protoporphyrin IX
1998
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
2019
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
2019
The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes
2016
Treatment of palmoplantar psoriasis with infliximab: a randomized, double‐blind placebo‐controlled study
2011
Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata
2003
Multiple Large-Surface Photodynamic Therapy Sessions with Topical or Systemic Aminolevulinic Acid and Blue Light in UV-Exposed Hairless Mice
2004
Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population
2010
A New Calcipotriol/Betamethasone Dipropionate Formulation (Daivobet<sup>TM</sup>) Is an Effective Once-Daily Treatment for Psoriasis vulgaris
2002
Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis
2020
TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study
2017
Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
2014
Efficacy and Tolerability of Topical Tacrolimus Ointment for the Treatment of Male Genital Psoriasis
2008
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial
2008
Effects of the Tumor Necrosis Factor-α Antagonist Adalimumab on Arterial Inflammation Assessed by Positron Emission Tomography in Patients With Psoriasis
2012
A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept
2011
A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis
2016
Etanercept for the treatment of psoriasis.
2006
Multiple Large-Surface Photodynamic Therapy Sessions with Topical or Systemic Aminolevulinic Acid and Blue Light in UV-Exposed Hairless Mice
2004
Safety of Conventional Systemic Agents and Biologic Agents in the Treatment of Psoriasis
2009
The oral Janus kinase/spleen tyrosine kinase inhibitorASN 002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
2019
Oral Aminolevulinic Acid Induces Protoporphyrin IX Fluorescence in Psoriatic Plaques and Peripheral Blood Cells†¶
2001
Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis
2014
Topical photodynamic therapy with 5‐aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata
2000
Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials
2020
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.
2010
Photodynamic Therapy with 5-Aminolevulinic Acid Induces Apoptosis and Caspase Activation in Malignant T Cells
2001
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis
2010
CURRENT STATUS OF PHOTODYNAMIC THERAPY IN DERMATOLOGY
1997
An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids
2010
Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis
2019
Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study
2017
Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
2018